Patents by Inventor Celine Tarnus

Celine Tarnus has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USE OF BISMUTH SUBSALICYLATE OR ONE OF THE DERIVATIVES THEREOF AS A PHYTOPHARMACEUTICAL AGENT
    Publication number: 20170311603
    Abstract: The invention relates to the use of bismuth subsalicylate or one of the derivatives thereof as a phytopharmaceutical agent, in particular for the treatment or prevention of fungal diseases in plants.
    Type: Application
    Filed: October 30, 2015
    Publication date: November 2, 2017
    Inventors: CHRISTOPHE BERTSCH, SEBASTIEN ALBRECHT, CELINE TARNUS, MELANIE GELLON
  • AMINOBENZOCYCLOHEPTENE DERIVATIVES, METHODS FOR PREPARING THE SAME AND USES THEREOF IN THERAPY
    Publication number: 20100069504
    Abstract: A compound of the general formula (I) as an active principle for treating cancer, specifically tumors, in particular diseases involving inhibition of metalloproteases, such as Aminopeptidase-N. Pharmaceutical compositions comprising the compound of general formula (I). Methods of treatment using the compound of general formula (I).
    Type: Application
    Filed: October 31, 2007
    Publication date: March 18, 2010
    Applicants: UNIVERSITE DE HAUTE ALSACE, UNIVERSITE LOUIS PASTEUR
    Inventors: Céline Tarnus-Rondeau, Albert Defoin, Sébastien Albrecht, Anamaria Maiereanu, Nadège Faux, Patrick Pale
  • Angiogenesis inhibitors and pharmaceutical/cosmetic applications thereof
    Patent number: 7396953
    Abstract: Novel derivatives of fumagalone have the general formula (I): and are useful angiogenes is inhibitors; these can be formulated into pharmaceutical compositions suited for human or veterinary medicine, or can be formulated into cosmetic compositions.
    Type: Grant
    Filed: December 21, 2006
    Date of Patent: July 8, 2008
    Assignees: Galderma Research & Development, CNRS
    Inventors: Jacques Eustache, Pierre Van De Weghe, Vincent Rodeschini, Celine Tarnus
  • Novel Angiogenesis inhibitors and pharmaceutical/cosmetic applications thereof
    Publication number: 20070167519
    Abstract: Novel derivatives of fumagalone have the general formula (I): and are useful angiogenes is inhibitors; these can be formulated into pharmaceutical compositions suited for human or veterinary medicine, or can be formulated into cosmetic compositions.
    Type: Application
    Filed: December 21, 2006
    Publication date: July 19, 2007
    Applicants: GALDERMA RESEARCH & DEVELOPMENT, CNRS
    Inventors: Jacques Eustache, Pierre Weghe, Vincent Rodeschini, Celine Tarnus
  • Angiogenesis inhibitors and pharmaceutical and cosmetic use thereof
    Patent number: 6803382
    Abstract: The invention relates to novel 1-oxaspiro[2,5]octan-6-ol derivatives of general formula (I): and also to a method for preparing them, and to their use in pharmaceutical compositions for use in human or veterinary medicine, or in cosmetic compositions.
    Type: Grant
    Filed: November 8, 2002
    Date of Patent: October 12, 2004
    Assignee: Galderma Research & Development, S.N.C.
    Inventors: Jacques Eustache, Jean-Guy Boiteau, Céline Tarnus, Vincent Rodeschini, Pierre Van De Weghe
  • Novel angiogenesis inhibitors and pharmaceutical and cosmetic use thereof
    Publication number: 20030134896
    Abstract: The invention relates to novel 1-oxaspiro[2,5]octan-6-ol derivatives of general formula (1): 1
    Type: Application
    Filed: November 8, 2002
    Publication date: July 17, 2003
    Inventors: Jacques Eustache, Jean-Guy Boiteau, Celine Tarnus, Vincent Rodeschini, Pierre Van De Weghe
  • Difluoro statone analogs
    Patent number: 6114380
    Abstract: This invention relates to novel difluoro statone analogs, to the processes and intermediates useful for their preparation and to their use as anti-viral agents.
    Type: Grant
    Filed: September 8, 1997
    Date of Patent: September 5, 2000
    Assignee: Merrell Pharmaceuticals Inc.
    Inventors: Daniel Schirlin, Viviane Van Dorsselaer, Celine Tarnus
  • Difluoro statone antiviral analogs
    Patent number: 5948778
    Abstract: This invention relates to novel statone antiviral analogs, to the processes and intermediates useful for their preparation and to their use as antiviral agents.
    Type: Grant
    Filed: May 19, 1998
    Date of Patent: September 7, 1999
    Assignee: Merrel Pharmaceuticals Inc.
    Inventors: Viviane Van Dorsselaer, Daniel Schirlin, Celine Tarnus
  • Difluoro statone antiviral analogs
    Patent number: 5831094
    Abstract: The present invention relates to difluorostatone derivatives useful as antiviral agents.
    Type: Grant
    Filed: February 20, 1996
    Date of Patent: November 3, 1998
    Assignee: Merrell Pharamceuticals Inc.
    Inventors: Viviane Van Dorsselaer, Daniel Schirlin, Celine Tarnus
  • Difluoro statone analogs
    Patent number: 5717093
    Abstract: This invention relates to novel difluoro statone analogs, to the processes and intermediates useful for their preparation and to their use as anti-viral agents.
    Type: Grant
    Filed: December 18, 1995
    Date of Patent: February 10, 1998
    Assignee: Merrell Pharmaceuticals Inc.
    Inventors: Daniel Schirlin, Viviane Van Dorsselaer, Celine Tarnus
  • Anti-viral compounds
    Patent number: 5716973
    Abstract: This invention relates to novel difluoro statone analogs, to the processes and intermediates useful for their preparation and to their use as anti-vital agents.
    Type: Grant
    Filed: January 23, 1997
    Date of Patent: February 10, 1998
    Assignee: Merrell Pharmaceuticals Inc.
    Inventors: Daniel Schirlin, Viviane Van Dorsselaer, Celine Tarnus
  • Difluoro statone analogs
    Patent number: 5559140
    Abstract: This invention relates to novel difluoro statone analogs, to the processes and intermediates useful for their preparation and to their use as anti-viral agents.
    Type: Grant
    Filed: June 30, 1993
    Date of Patent: September 24, 1996
    Assignee: Merrell Pharmaceuticals Inc.
    Inventors: Daniel Schirlin, Viviane Van Dorsselaer, Celine Tarnus
  • Thrombin inhibitors
    Patent number: 5498779
    Abstract: This invention relates to novel polyfluorinated alkyl derivatives of certain tripeptides, to the methods for their preparation, the intermediates therefore, to their use in inhibiting thrombin and lung tryptase and in their end-use application as anti-coagulants useful in treating thrombophlebitis and coronary thrombosis and in the treatment of asthma.
    Type: Grant
    Filed: May 22, 1995
    Date of Patent: March 12, 1996
    Assignee: Merrell Pharmaceuticals Inc.
    Inventors: Bernhard Neises, Axel Ganzhorn, Celine Tarnus, Robert J. Broersma, Jr.
  • Polyfluorinated tripeptide thrombin inhibitors
    Patent number: 5391705
    Abstract: This invention relates to novel polyfluorinated alkyl derivatives of certain tripeptides, to the methods for their preparation, the intermediates therefore, to their use in inhibiting thrombin and lung tryptase and in their end-use application as anti-coagulants useful in treating thrombophlebitis and coronary thrombosis and in the treatment of asthma.
    Type: Grant
    Filed: February 18, 1994
    Date of Patent: February 21, 1995
    Assignee: Merrell Dow Pharmaceuticals Inc.
    Inventors: Bernhard Neises, Axel Ganzhorn, Celine Tarnus, Robert J. Broersma, Jr.
  • Method of using certain tetralin derivatives to produce analgesic relief
    Patent number: 5106861
    Abstract: This invention relates to novel derivatives of tetralin, to the processes for their preparation, to their use as amino-peptidase inhibitors and to their end-use application as immunomodulators and as analgesic agents.
    Type: Grant
    Filed: May 22, 1991
    Date of Patent: April 21, 1992
    Assignee: Merrell Dow Pharmaceuticals Inc.
    Inventors: Hugues d'Orchymont, Celine Tarnus
  • Novel tetralin derivatives
    Patent number: 5041673
    Abstract: This invention relates to novel derivatives of tetralin, to the processes for their preparation, to their use as aminopeptidase inhibitors and to their end-use application as immunomodulators and as analgesic agents.
    Type: Grant
    Filed: January 4, 1990
    Date of Patent: August 20, 1991
    Assignee: Merrell Dow Pharmaceuticals Inc.
    Inventors: Hugues d'Orchymont, Celine Tarnus